Revvity Inc (NYSE:RVTY)
$ 105.63 +5.73 (+5.74%) Market Cap: 11.78 Bil Enterprise Value: 14.27 Bil PE Ratio: 50.54 PB Ratio: 1.64 GF Score: 77/100

Revvity Inc at Barclays Global Healthcare Conference Transcript

Mar 10, 2026 / 02:30 PM GMT
Release Date Price: $90.3 (-1.97%)


Refinitiv StreetEvents Event Transcript
E D I T E D V E R S I O N

RVTY.N - Revvity Inc
Revvity Inc at Barclays Global Healthcare Conference
Mar 10, 2026 / 02:30PM GMT

=====================
Presentation
--------------------------------------------------------------------------------
Unidentified_1 [1]
--------------------------------------------------------------------------------
Good morning, everybody. I'm Luke Serga. I cover Life Science tools and diagnostics from Barclays. With me, I have Pralad Singh, CEO of Revity, two Vs in Revity, and we have Steve Willoughby from IR here as well. So, let's start off, and we were just kinda talking about it, like you never got credit for signals before.

And now all of a sudden with cloud updates, now it's like a huge issue with you guys. And You have significant launches across the platform. If you can kind of just walk us through like a one on one of what's in your signals business or or just in and also with the new launches, but Talk about the customers that you guys serve, the lump the, not the lumpiness, the stickiness there, the data access, like what
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot